Psychemedics Corp Files 8-K on Security Holder Vote

Ticker: PMDI · Form: 8-K · Filed: Nov 25, 2024 · CIK: 806517

Psychemedics Corp 8-K Filing Summary
FieldDetail
CompanyPsychemedics Corp (PMDI)
Form Type8-K
Filed DateNov 25, 2024
Risk Levellow
Pages3
Reading Time4 min
Key Dollar Amounts$0.005
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

TL;DR

Psychemedics Corp is putting stuff to a shareholder vote. Details TBD.

AI Summary

On November 25, 2024, Psychemedics Corporation filed an 8-K report indicating that it is submitting matters to a vote of its security holders. The filing does not contain details about the specific matters to be voted on or the outcome of any vote.

Why It Matters

This filing signals that Psychemedics Corporation is engaging its shareholders in decision-making processes, which could impact corporate governance and future strategic directions.

Risk Assessment

Risk Level: low — The filing is procedural and does not disclose any immediate financial or operational risks.

Key Players & Entities

  • PSYCHEMEDICS CORPORATION (company) — Registrant
  • Delaware (jurisdiction) — State of Incorporation
  • November 25, 2024 (date) — Date of Report

FAQ

What specific matters are being submitted to a vote of Psychemedics Corporation's security holders?

The filing does not specify the exact matters to be voted on by security holders.

When was this 8-K report filed?

The report was filed on November 25, 2024.

What is Psychemedics Corporation's state of incorporation?

Psychemedics Corporation is incorporated in Delaware.

What is the principal executive office address for Psychemedics Corporation?

The principal executive offices are located at 5220 Spring Valley Road, Suite 230, Dallas, Texas 75254.

Does this filing indicate any changes to Psychemedics Corporation's former name or address?

The filing states 'N/A' for former name or former address, indicating no changes have been reported.

Filing Stats: 1,018 words · 4 min read · ~3 pages · Grade level 11.6 · Accepted 2024-11-25 17:24:03

Key Financial Figures

  • $0.005 — nge on which registered Common stock. $0.005 par value per share PMD The NASDAQ St

Filing Documents

07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. The final results for each of the matters submitted to a vote of stockholders at the annual meeting of stockholders (the "Annual Meeting") of Psychemedics Corporation (the "Company") are set forth below. A more detailed description of each proposal is set forth in the Company's definitive proxy statement on Schedule 14A, filed with the U.S. Securities and Exchange Commission on October 18, 2024 (the "Proxy Statement"). Proposal No. 1. Election of Directors. The stockholders re-elected five directors to the Company's Board of Directors (the "Board") to serve until the Company's 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified, by the votes set forth in the table below: Nominees For Against Abstain Broker Non-Votes Robyn C. Davis 3,719,463 358,953 34,673 1,104,904 Brian Hullinger 3,727,163 351,202 34,724 1,104,904 Peter H. Kamin 3,717,255 384,797 11,037 1,104,904 Darius G. Nevin 3,704,668 373,763 34,658 1,104,904 Andrew M. Reynolds 3,719,488 358,943 34,658 1,104,904 Proposal No. 2. Advisory Vote on Executive Compensation. The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as described in the Proxy Statement, by the votes set forth in the table below: For Against Abstain Broker Non-Votes 3,654,822 416,466 41,801 1,104,904 Proposal No. 3. Ratification of Appointment of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Whitley Penn LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024, by the votes set forth in the table below: For Against Abstain Broker Non-Votes 4,820,325 367,323 30,345 0 -2- Proposal No. 4. Approval of the amendment to the Company's amended and restated certificate of incor

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.